Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE)

The Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre works alongside volunteer patients from Cardiff and the Vale University Health Board, to develop and test drugs to treat patients with Rheumatoid and Psoriatic arthritis.

The CREATE Centre is part of the Rheumatology section within the School of Medicine.

We work alongside volunteer patients from Cardiff and the Vale University Health Board, to develop and test drugs to treat patients with Rheumatoid and Psoriatic arthritis. We are jointly funded by Arthritis Research UK, Health and Care Research Wales and Cardiff University.

Rheumatoid and Psoriatic Arthritis are chronic inflammatory joint conditions that result in pain, disability, joint damage and reduced quality of life. Achieving and sustaining remission has been shown to be important in arresting joint damage and improve prognosis. However, the percentage of patients who attain remission in clinical practice is estimated to be less than 30 per cent.

Aims

To improve the outcome of patients with rheumatoid and psoriatic arthritis by developing new treatments and diagnostic tests that will lead to more patients achieving disease remission.

If you would like to find out more about the centre or are interested in engaging with us please contact us by email.

We have established collaboration with other researchers in the area of infection and immunity to identify novel targets and develop new treatment.

Testing these novel treatments in patients with Rheumatoid and Psoriatic Arthritis will be facilitated by the South East Wales Trials Unit and the Clinical Research Facility at University Hospital of Wales.